Table 3.
Comparison of microbial susceptibility to antibacterial drugs in the study and control groups.
| Antibacterial agent | Control group | Study group | p | |
|---|---|---|---|---|
| P | N | 27 | 19 | p=0.6113 |
| Ns | 19 | 12 | ||
| % | 70.37 | 63.16 | ||
|
| ||||
| AUG | N | 32 | 27 | p=0.7517 |
| Ns | 25 | 22 | ||
| % | 78.13 | 81.48 | ||
|
| ||||
| Va | N | 25 | 19 | p=0.5375 |
| Ns | 18 | 12 | ||
| % | 72.00 | 63.16 | ||
|
| ||||
| TZP | N | 21 | 19 | p=0.5593 |
| Ns | 17 | 16 | ||
| % | 80.95 | 84.21 | ||
|
| ||||
| CC | N | 28 | 20 | p=0.1746 |
| Ns | 27 | 16 | ||
| % | 96.45 | 80.00 | ||
|
| ||||
| MZ | N | 25 | 17 | p=0.1204 |
| Ns | 10 | 11 | ||
| % | 40.00 | 64.71 | ||
|
| ||||
| G | N | 7 | 9 | p=1.0000 |
| Ns | 7 | 9 | ||
| % | 100 | 100.00 | ||
|
| ||||
| Bs | N | 10 | 9 | p=0.1238 |
| Ns | 7 | 9 | ||
| % | 70.00 | 100.00 | ||
|
| ||||
| CXM | N | 7 | 7 | p=0.5000 |
| Ns | 7 | 6 | ||
| % | 100.00 | 85.71 | ||
|
| ||||
| CIP | N | 7 | 9 | p=0.5625 |
| Ns | 7 | 8 | ||
| % | 100.00 | 88.89 | ||
|
| ||||
| FEP | N | 7 | 7 | p=0.0962 |
| Ns | 4 | 7 | ||
| % | 57.14 | 100.00 | ||
|
| ||||
| AM | N | 7 | 7 | p=0.5000 |
| Ns | 0 | 1 | ||
| % | 0.00 | 14.29 | ||
P, penicillin; AUG, amoxicillin with clavulanic acid; Va, vancomycin; TZP, piperacillin with tazobactam; CC, clindamycin; MZ, metronidazole; G, gentamicin; Bs, sulfamethoxazole with trimethoprim (biseptol); CXM, cefuroxime; CIP, ciprofloxacin; FEP, cefepime; AM, ampicillin.